Private company
New Enterprise Associates 14, L.P.
Company in the Cayman Islands incorporated in the Cayman Islands. Summary from the record
Last updated Oct 21, 2026.
Overview
- HeadquartersE91
Corporate structure
New Enterprise Associates 14, L.P. sits at the top of its group. 11 entities, 3 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- New Enterprise Associates 14, L.P. E9
- Adaptimmune (United Kingdom) Stake · Abingdon-on-Thames
- Casper Sleep Inc. Stake · New York, New York
- Champions Oncology Stake · Hackensack, New Jersey, United States
- Enliven Therapeutics, Inc. Stake · Burlingame, California
- LUMOS PHARMA, INC. Stake · Austin, Texas
- NEXTNAV INC. Stake · Reston, Virginia
- Oyster Point Pharma, Inc. Stake · Princeton, New Jersey
- SYNLOGIC, INC. Stake · Winchester, Massachusetts
- Tuya Inc. Stake · E9
- ZeroFox Stake · Baltimore, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (10 companies). Each entity in the chart links to its source.
Filings
2 filings to the SEC since October 2021: 2 other. The latest 2:
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
New Enterprise Associates 14, L.P. has told the SEC it owns more than 5% of 10 companies, latest first (Schedules 13D and 13G).
- SYNLOGIC, INC.SCHEDULE 13D/A Oct 13, 2023 to Jul 29, 20262
- Adaptimmune (United Kingdom)SCHEDULE 13D/A Mar 30, 2023 to Aug 19, 20253
- Tuya Inc.SCHEDULE 13G/A Feb 15, 2022 to Feb 14, 20254
- NEXTNAV INC.SCHEDULE 13D/A Dec 1, 2021 to Jan 7, 20255
- ZeroFoxSC 13D/A Aug 12, 2022 to May 15, 20246
- Champions OncologySC 13D/A May 6, 20247
- Oyster Point Pharma, Inc.SC 13D/A Nov 21, 2022 to Jan 9, 20238
- Enliven Therapeutics, Inc.SC 13D/A Jan 10, 2022 to May 24, 20229
- LUMOS PHARMA, INC.SC 13D/A Jan 5, 202210
- Casper Sleep Inc.SC 13D/A Nov 22, 202111
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11